Research study will explore possible link with cytokine profiles, differences between men and women The Smith Alzheimer’s Center and Simmons Cancer Institute are teaming up to better understand the common side effect of “chemobrain,” and why some patients are at higher risk of developing it than others. Aida Adlimoghaddam, PhD of the Smith Alzheimer’s Center and Krishna Rao, MD of Simmons Cancer Institute received the Team Science Grant to explore the cytokine profiles (proteins that send signals throughout the body) that could contribute to variations in susceptibility to inflammation and
